Crinetics adopts non-qualified deferred compensation plan for executives and directors

Crinetics Pharmaceuticals, Inc.

Plan effective April 1, 2024; allows deferral of salary, fees, bonuses, and time-based RSUs.
Participation limited to select management, highly compensated employees, and non-employee directors.
Company may make matching or discretionary contributions; elective deferrals and matching fully vested.
Payments generally made after separation from service or at elected in-service payment date.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.